Sarcopenia in older people

International Journal of Evidence-Based Healthcare

Volumn 12, Issue 4, 2014, Pages 227-243

  Yu, Solomon ^a,b   Umapathysivam, Kandiah ^a   Visvanathan, Renuka ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

Aging; Body composition; Muscle mass; Nutrition; Sarcopenias

Indexed keywords

VITAMIN D;

AGED; AGING; AUSTRALIA; BODY MASS; CARDIOVASCULAR DISEASES; COMORBIDITY; DIET; DIET SUPPLEMENTATION; FALLING; HUMAN; MASS SCREENING; METABOLIC DISEASES; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PHYSIOTHERAPY; PREVALENCE; SARCOPENIA; STANDARDS; TRENDS;

ACCIDENTAL FALLS; AGED; AGING; AUSTRALIA; BODY MASS INDEX; CARDIOVASCULAR DISEASES; COMORBIDITY; DIET; DIETARY SUPPLEMENTS; HUMANS; MASS SCREENING; METABOLIC DISEASES; MOTOR ACTIVITY; PHYSICAL THERAPY MODALITIES; PREVALENCE; SARCOPENIA; VITAMIN D;

EID: 84926675076     PISSN: 17441595     EISSN: 17441609     Source Type: Journal    
DOI: 10.1097/XEB.0000000000000018     Document Type: Article

References (116)

1. Steen B. Body composition and aging. Nutr Rev 1988; 46: 45-51.
2. Omran ML, Morley JE. Assessment of protein energy malnutrition in older persons, part I: history, examination, body composition, and screening tools. Nutrition 2000; 16: 50-63.
3. Hughes VA, Frontera WR, Roubenoff R, et al. Longitudinal changes in body composition in older men and women: role of body weight change and physical activity. Am J Clin Nutr 2002; 76: 473-81.
4. Beaufrere B, Morio B. Fat and protein redistribution with aging: metabolic considerations. Eur J Clin Nutr 2000; 54 (Suppl 3): S48-53.
5. Borkan GA, Hults DE, Gerzof SG, Robbins AH. Comparison of body composition in middle-aged and elderly males using computed tomography. Am J Phys Anthropol 1985; 66: 289-95.
6. Grimby G, Saltin B. The ageing muscle. Clin Physiol 1983; 3: 209-18.
7. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr 1997; 127 (5 Suppl). 990S-1S.
8. Roubenoff R. Sarcopenia and its implications for the elderly. Eur J Clin Nutr 2000; 54 (Suppl 3): S40-7.
9. Abellan van Kan G, Andre E, Bischoff Ferrari HA, et al. Carla Task Force on sarcopenia: propositions for clinical trials. J Nutr Health Aging 2009; 13: 700-7.
10. Muscaritoli M, Anker SD, Argiles J, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) 'cachexia-anorexia in chronic wasting diseases' and 'nutrition in geriatrics'. Clin Nutr 2010; 29: 154-9.
11. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010; 39: 412-23.
12. Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998; 147: 755-63.
13. Newman AB, Kupelian V, Visser M, et al. Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc 2003; 51: 1602-9.
14. Chien MY, Huang TY, Wu YT. Prevalence of sarcopenia estimated using a bioelectrical impedance analysis prediction equation in community-dwelling elderly people in Taiwan. J Am Geriatr Soc 2008; 56: 1710-5.
15. Lauretani F, Russo CR, Bandinelli S, et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol 2003; 95: 1851-60.
16. Guralnik JM, Ferrucci L, Pieper CF, et al. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci 2000; 55: M221-31.
17. Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 2011; 12: 249-56.
18. Morley JE, Abbatecola AM, Argiles JM, et al. Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc 2011; 12: 403-9.
19. Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus report of the asian working group for sarcopenia. J Am Med Dir Assoc 2014; 15: 95-101.
20. Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci 2014; 69: 547-58.
21. Dam TT, Peters KW, Fragala M, et al. An evidencebased comparison of operational criteria for the presence of sarcopenia. J Gerontol A Biol Sci Med Sci 2014; 69: 584-90.
22. Scott D, Hayes A, Sanders KM, et al. Operational definitions of sarcopenia and their associations with 5-year changes in falls risk in community-dwelling middle-aged and older adults. Osteoporos Int 2013; 25: 187-93.
23. Legrand D, Vaes B, Mathei C, et al. The prevalence of sarcopenia in very old individuals according to the European consensus definition: insights from the BELFRAIL study. Age Ageing 2013; 42: 727-34.
24. Patel HP, Syddall HE, Jameson K, et al. Prevalence of sarcopenia in community-dwelling older people in the UK using the European Working Group on Sarcopenia in Older People (EWGSOP) definition: findings from the Hertfordshire Cohort Study (HCS). Age Ageing 2013; 42: 378-84.
25. Volpato S, Bianchi L, Cherubini A, et al. Prevalence and clinical correlates of sarcopenia in community-dwelling older people: application of the EWGSOP definition and diagnostic algorithm. J Gerontol A Biol Sci Med Sci 2013; 69: 438-46.
26. Patil R, Uusi-Rasi K, Pasanen M, et al. Sarcopenia and osteopenia among 70-80-year-old home-dwelling Finnish women: prevalence and association with functional performance. Osteoporos Int 2012; 24: 787-96.
27. Lin CC, Lin WY, Meng NH, et al. Sarcopenia prevalence and associated factors in an elderly Taiwanese metropolitan population. J Am Geriatr Soc 2013; 61: 459-62.
28. Lee WJ, Liu LK, Peng LN, et al. Comparisons of sarcopenia defined by IWGS and EWGSOP criteria among older people: results from the I-Lan longitudinal aging study. J Am Med Dir Assoc 2013; 14: 528; e1-7.
29. Yoshida D, Suzuki T, Shimada H, et al. Using two different algorithms to determine the prevalence of sarcopenia. Geriatr Gerontol Int 2014; 14 (Suppl 1): 46-51.
30. Landi F, Liperoti R, Fusco D, et al. Sarcopenia and mortality among older nursing home residents. J Am Med Dir Assoc 2012; 13: 121-6.
31. Smoliner C, Sieber CC, Wirth R. Prevalence of sarcopenia in geriatric hospitalized patients. J Am Med Dir Assoc 2014; 15: 267-72.
32. Bijlsma AY, Meskers CG, Ling CH, et al. Defining sarcopenia: the impact of different diagnostic criteria on the prevalence of sarcopenia in a large middle aged cohort. Age (Dordr) 2012; 35: 871-81.
33. Scott D, Hayes A, Sanders KM, et al. Operational definitions of sarcopenia and their associations with 5-year changes in falls risk in community-dwelling middle-aged and older adults. Osteoporos Int 2013; 25: 187-93.
34. Landi F, Liperoti R, Russo A, et al. Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study. Clin Nutr 2012; 31: 652-8.
35. Cederholm T, Cruz-Jentoft AJ, Maggi S. Sarcopenia and fragility fractures. Eur J Phys Rehabil Med 2013; 49: 111-7.
36. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 2002; 50: 889-96.
37. Karakelides H, Nair KS. Sarcopenia of aging and its metabolic impact. Curr Top Dev Biol 2005; 68: 123-48.
38. Aubertin-Leheudre M, Lord C, Goulet ED, et al. Effect of sarcopenia on cardiovascular disease risk factors in obese postmenopausal women. Obesity (Silver Spring) 2006; 14: 2277-83.
39. Stephen WC, Janssen I. Sarcopenic-obesity and cardiovascular disease risk in the elderly. J Nutr Health Aging 2009; 13: 460-6.
40. Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc 2004; 52: 80-5.
41. ABS. Population projections, Australia. Canberra: ABS; 2013.
42. Grimes DA, Schulz KF. Uses and abuses of screening tests. Lancet 2002; 359: 881-4.
43. Goodman MJ, Ghate SR, Mavros P, et al. Development of a practical screening tool to predict low muscle mass using NHANES 1999-2004. J Cachexia Sarcopenia Muscle 2013; 4: 187-97.
44. Ishii S, Tanaka T, Shibasaki K, et al. Development of a simple screening test for sarcopenia in older adults. Geriatr Gerontol Int 2014; 14 (Suppl 1): 93-101.
45. Malmstrom TK, Morley JE. SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc 2013; 14: 531-2.
46. Safer U, Tasci I, Safer VB, Doruk H. Accurate diagnosis of sarcopenia in the elderly requires correct measurement of muscle mass. Clin Nutr 2013; 32: 662.
47. Vermeulen J, Neyens JC, van Rossum E, et al. Predicting ADL disability in community-dwelling elderly people using physical frailty indicators: a systematic review. BMC Geriatr 2011; 11: 33.
48. Podsiadlo D, Richardson S. The timed 'Up & Go': a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 1991; 39: 142-8.
49. Roberts HC, Denison HJ, Martin HJ, et al. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing 2011; 40: 423-9.
50. Cooper C, Fielding R, Visser M, et al. Tools in the assessment of sarcopenia. Calcif Tissue Int 2013; 93: 201-10.
51. Pahor M, Manini T, Cesari M. Sarcopenia: clinical evaluation, biological markers and other evaluation tools. J Nutr Health Aging 2009; 13: 724-8.
52. Cooper C, Dere W, Evans W, et al. Frailty and sarcopenia: definitions and outcome parameters. Osteoporos Int 2012; 23: 1839-48.
53. Mijnarends DM, Meijers JM, Halfens RJ, et al. Validity and reliability of tools to measure muscle mass, strength, and physical performance in community-dwelling older people: a systematic review. J Am Med Dir Assoc 2013; 14: 170-8.
54. Heymsfield SB, Smith R, Aulet M, et al. Appendicular skeletal muscle mass: measurement by dual-photon absorptiometry. Am J Clin Nutr 1990; 52: 214-8.
55. Haarbo J, Gotfredsen A, Hassager C, Christiansen C. Validation of body composition by dual energy X-ray absorptiometry (DEXA). Clin Physiol 1991; 11: 331-41.
56. Tothill P. Dual-energy X-ray absorptiometry for the measurement of bone and soft tissue composition. Clin Nutr 1995; 14: 263-8.
57. Plank LD. Dual-energy X-ray absorptiometry and body composition. Curr Opin Clin Nutr Metab Care 2005; 8: 305-9.
58. Delmonico MJ, Kostek MC, Johns J, et al. Can dual energy X-ray absorptiometry provide a valid assessment of changes in thigh muscle mass with strength training in older adults? Eur J Clin Nutr 2008; 62: 1372-8.
59. Sierra M, Machado C. Magnetic resonance imaging in patients with implantable cardiac devices. Rev Cardiovasc Med 2008; 9: 232-8.
60. McIsaac HK, Thordarson DS, Shafran R, et al. Claustrophobia and the magnetic resonance imaging procedure. J Behav Med 1998; 21: 255-68.
61. Kyle UG, Bosaeus I, De Lorenzo AD, et al. Bioelectrical impedance analysis: part I: review of principles and methods. Clin Nutr 2004; 23: 1226-43.
62. Tanko LB, Movsesyan L, Mouritzen U, et al. Appendicular lean tissue mass and the prevalence of sarcopenia among healthy women. Metabolism 2002; 51: 69-74.
63. Wen X, Wang M, Jiang CM, Zhang YM. Anthropometric equation for estimation of appendicular skeletal muscle mass in Chinese adults. Asia Pac J Clin Nutr 2011; 20: 551-6.
64. Visvanathan R, Yu S, Field J, et al. Appendicular skeletal muscle mass: development and validation of anthropometric prediction equations. J Frailty Aging 2012; 1: 147- 51.
65. Kulkarni B, Kuper H, Taylor A, et al. Development and validation of anthropometric prediction equations for estimation of lean body mass and appendicular lean soft tissue in Indian men and women. J Appl Physiol (1985) 2013; 115: 1156-62.
66. Pereira PG, da Silva GA, Santos GMJ Jr, et al. Development and validation of anthropometric equations to estimate appendicular muscle mass in elderly women. Nutr J 2013; 12: 92.
67. Lera L, Albala C, Angel B, et al. [Anthropometric model for the prediction of appendicular skeletal muscle mass in Chilean older adults.]. Nutr Hosp 2014; 29: 611-7.
68. Boirie Y. Physiopathological mechanism of sarcopenia. J Nutr Health Aging 2009; 13: 717-23.
69. Collins-Hooper H, Woolley TE, Dyson L, et al. Age-related changes in speed and mechanism of adult skeletal muscle stem cell migration. Stem Cells 2012; 30: 1182-95.
70. Joseph AM, Adhihetty PJ, Buford TW, et al. The impact of aging on mitochondrial function and biogenesis pathways in skeletal muscle of sedentary high- and low-functioning elderly individuals. Aging Cell 2012; 11: 801-9.
71. Drey M, Krieger B, Sieber CC, et al. Motoneuron loss is associated with sarcopenia. J Am Med Dir Assoc 2014; 15: 435-9.
72. Chai RJ, Vukovic J, Dunlop S, et al. Striking denervation of neuromuscular junctions without lumbar motoneuron loss in geriatric mouse muscle. PLoS One 2011; 6: e28090.
73. Bruunsgaard H, Pedersen BK. Age-related inflammatory cytokines and disease. Immunol Allergy Clin North Am 2003; 23: 15-39.
74. Chapman IM. The anorexia of aging. Clin Geriatr Med 2007; 23: 735-56.
75. Buchanan JB, Johnson RW. Regulation of food intake by inflammatory cytokines in the brain. Neuroendocrinology 2007; 86: 183-90.
76. Ferrucci L, Penninx BW, Volpato S, et al. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J Am Geriatr Soc 2002; 50: 1947-54.
77. Schaap LA, Pluijm SMF, Deeg DJH, et al. Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. J Gerontol A Biol Sci Med Sci 2009; 64A: 1183-9.
78. Morley JE, Perry HMJ 3rd. Androgen deficiency in aging men: role of testosterone replacement therapy. J Lab Clin Med 2000; 135: 370-8.
79. Ottenbacher KJ, Ottenbacher ME, Ottenbacher AJ, et al. Androgen treatment and muscle strength in elderly men: a meta-analysis. J Am Geriatr Soc 2006; 54: 1666-73.
80. Basaria S, Coviello AD, Travison TG, et al. Adverse events associated with testosterone administration. N Engl J Med 2010; 363: 109-22.
81. Yarasheski KE, Zachwieja JJ, Campbell JA, Bier DM. Effect of growth hormone and resistance exercise on muscle growth and strength in older men. Am J Physiol 1995; 268 (2 Pt 1): E268-76.
82. Taaffe DR, Pruitt L, Reim J, et al. Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men. J Clin Endocrinol Metab 1994; 79: 1361-6.
83. Visvanathan R, Chapman I. Preventing sarcopaenia in older people. Maturitas 2010; 66: 383-8.
84. Rolland Y, Czerwinski S, Abellan Van Kan G, et al. Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging 2008; 12: 433-50.
85. Roubenoff R. Sarcopenia: a major modifiable cause of frailty in the elderly. J Nutr Health Aging 2000; 4: 140-2.
86. Morley J. Sarcopenia: Diagnosis and treatment. J Nutr Health Aging 2008; 12: 452-6.
87. Chao D, Foy CG, Farmer D. Exercise adherence among older adults: challenges and strategies. Control Clin Trials 2000; 21 (5 Suppl): S212-7.
88. Montero-Fernandez N, Serra-Rexach JA. Role of exercise on sarcopenia in the elderly. Eur J Phys Rehabil Med 2013; 49: 131-43.
89. Haskell WL, Lee IM, Pate RR, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation 2007; 116: 1081-93.
90. Coggan AR, Spina RJ, King DS, et al. Skeletal muscle adaptations to endurance training in 60- to 70-yr-old men and women. J Appl Physiol (1985) 1992; 72: 1780-6.
91. Lemura LM, von Duvillard SP, Mookerjee S. The effects of physical training of functional capacity in adults. Ages 46 to 90: a meta-analysis. J Sports Med Phys Fitness 2000; 40: 1-10.
92. Lepretre PM, Vogel T, Brechat PH, et al. Impact of shortterm aerobic interval training on maximal exercise in sedentary aged subjects. Int J Clin Pract 2009; 63: 1472-8.
93. Yarasheski KE, Pak-Loduca J, Hasten DL, et al. Resistance exercise training increases mixed muscle protein synthesis rate in frail women and men
94. Jozsi AC, Campbell WW, Joseph L, et al. Changes in power with resistance training in older and younger men and women. J Gerontol A Biol Sci Med Sci 1999; 54: M591-6.
95. Fiatarone MA, O'Neill EF, Ryan ND, et al. Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med 1994; 330: 1769-75.
96. Schulte JN, Yarasheski KE. Effects of resistance training on the rate of muscle protein synthesis in frail elderly people. Int J Sport Nutr Exerc Metab 2001; 11 (Suppl): S111-8.
97. Orr R, Raymond J, Fiatarone Singh M. Efficacy of progressive resistance training on balance performance in older adults: a systematic review of randomized controlled trials. Sports Med 2008; 38: 317-43.
98. Nelson ME, Rejeski WJ, Blair SN, et al. Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Circulation 2007; 116: 1094-105.
99. Bischoff Ferrari HA. Validated treatments and therapeutic perspectives regarding nutritherapy. J Nutr Health Aging 2009; 13: 737-41.
100. Wicherts IS, van Schoor NM, Boeke AJ, et al. Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab 2007; 92: 2058-65.
101. Bischoff HA, Stahelin HB, Dick W, et al. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 2003; 18: 343-51.
102. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. J Am Med Assoc 2002; 288: 1723-7.
103. Heiat A, Vaccarino V, Krumholz HM. An evidence-based assessment of federal guidelines for overweight and obesity as they apply to elderly persons. Arch Intern Med 2001; 161: 1194-203.
104. Waters DL, Ward AL, Villareal DT. Weight loss in obese adults 65 years and older: a review of the controversy. Exp Gerontol 2013; 48: 1054-61.
105. Truswell A, Cole-Ruthishauser I, Dresoti I, English R. Recommended dietary allowance: Australian Goverment Publishing Service1991.
106. Bauer J, Biolo G, Cederholm T, et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc 2013; 14: 542-59.
107. Bouillanne O, Curis E, Hamon-Vilcot B, et al. Impact of protein pulse feeding on lean mass in malnourished and at-risk hospitalized elderly patients: a randomized controlled trial. Clin Nutr 2012; 32: 186-92.
108. Esmarck B, Andersen JL, Olsen S, et al. Timing of postexercise protein intake is important for muscle hypertrophy with resistance training in elderly humans. J Physiol 2001; 535 (Pt 1): 301-11.
109. Dillon EL, Sheffield-Moore M, Paddon-Jones D, et al. Amino acid supplementation increases lean body mass, basal muscle protein synthesis, and insulin-like growth factor-I expression in older women. J Clin Endocrinol Metab 2009; 94: 1630-7.
110. Wall BT, Hamer HM, de Lange A, et al. Leucine co-ingestion improves post-prandial muscle protein accretion in elderly men. Clin Nutr 2012; 32: 412-9.
111. Cooper R, Naclerio F, Allgrove J, Jimenez A. Creatine supplementation with specific view to exercise/sports performance: an update. J Int Soc Sports Nutr 2012; 9: 33.
112. Brose A, Parise G, Tarnopolsky MA. Creatine supplementation enhances isometric strength and body composition improvements following strength exercise training in older adults. J Gerontol A Biol Sci Med Sci 2003; 58: 11-9.
113. Candow DG, Chilibeck PD. Effect of creatine supplementation during resistance training on muscle accretion in the elderly. J Nutr Health Aging 2007; 11: 185-8.
114. Fitschen PJ, Wilson GJ, Wilson JM, Wilund KR. Efficacy of beta-hydroxy-beta-methylbutyrate supplementation in elderly and clinical populations. Nutrition 2012; 29: 29-36.
115. Chumlea WC, Cesari M, Evans WJ, et al. Sarcopenia: designing phase IIB trials. J Nutr Health Aging 2011; 15: 450-5.
116. Onder G, Della Vedova C, Landi F. Validated treatments and therapeutics prospectives regarding pharmacological products for sarcopenia. J Nutr Health Aging 2009; 13: 746-56.